WebMar 23, 2024 · Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell engagers that harness the power of the … WebApr 1, 2024 · Harpoon Therapeutics Stock Up 7.7 % NASDAQ HARP opened at $0.74 on Friday. Harpoon Therapeutics has a twelve month low of $0.59 and a twelve month high of $5.16. The firm has a market...
Harpoon Therapeutics (HARP) Price To Cash Flow - Zacks.com
WebMar 22, 2024 · On March 22, 2024, Harpoon Therapeutics, Inc., a Delaware corporation (the "Company"), entered into a Securities Purchase Agreement (the "Purchase Agreement") with the purchasers named therein (the "Purchasers"), pursuant to which the Company agreed to sell and issue shares of the Company's 8.000% Series A … WebApr 10, 2024 · April 10, 2024 - 4:05 pm. SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immuno-oncology company developing novel T cell engagers, today announced that Julie Eastland, President and Chief Executive Officer, and Luke Walker, M.D., Chief Medical … hydrex 6105
Harpoon Therapeutics Immuno-oncology TriTAC™
WebMar 27, 2024 · SOUTH SAN FRANCISCO, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP) (the “Company”), a clinical-stage... Harpoon Therapeutics Announces Closing of $25 ... WebMar 27, 2024 · Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel … WebMar 27, 2024 · Harpoon Therapeutics is an immuno-oncology company using a proprietary technology platform focused on T cell engagement to discover and develop novel biologics for the treatment of cancer and … hydrex75